Docstoc

Ares Capital Corporation Closes First Venture Finance Transaction with Respicardia, Inc

Document Sample
Ares Capital Corporation Closes First Venture Finance Transaction with Respicardia, Inc Powered By Docstoc
					
				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:2
posted:8/6/2012
language:English
pages:2
Description: NEW YORK--(BUSINESS WIRE)--Ares Capital Corporation (NASDAQ: ARCC) announced today that it closed its first venture finance transaction with Respicardia®, Inc., an early stage company developing a medical device targeted to improve respiratory and cardiovascular health by treating central sleep apnea. Ares Capital served as lead agent in a $6 million senior secured credit facility to provide working capital for Respicardia’s completion of its pilot study. Respicardia is in the clinical trial pha a style='font-si
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.